BetterLife Pharma (BETRF) Current Assets (2011 - 2026)
BetterLife Pharma (BETRF) posted quarterly Current Assets of $15175.2 for Q1 2026, down 36.93% year-over-year from $24061.1 in Q1 2025, and down 36.93% quarter-over-quarter from $24061.1 in Q1 2025.
BetterLife Pharma (BETRF) Current Assets (2011 - 2026) Analysis & Trends
BetterLife Pharma's Current Assets history runs 16 years deep, the most recent figure standing at $15175.2 for Q1 2026.
- In Q1 2026, Current Assets fell 36.93% year-over-year to $15175.2; the TTM figure through Jan 2026 stood at $15175.2 (down 36.93% YoY), while the FY2026 annual figure was $15175.2, down 36.93% from the prior year.
- Current Assets for Q1 2026 stood at $15175.2, down from $24061.1 in the prior quarter.
- The five-year high for Current Assets was $903006.4 in Q1 2022, with the low at $15175.2 in Q1 2026.
- The 5-year median for Current Assets is $121917.7 (2022), against an average of $213581.6.
- Peak annual rise in Current Assets reached 12.62% in 2022, while the deepest fall reached 95.92% in 2022.
- BetterLife Pharma's Current Assets stood at $206732.3 in 2022, then plunged by 72.85% to $56128.0 in 2023, then slipped by 23.41% to $42991.1 in 2024, then tumbled by 44.03% to $24061.1 in 2025, then tumbled by 36.93% to $15175.2 in 2026.
- Business Quant data shows BETRF's Current Assets at $15175.2 in Q1 2026, $24061.1 in Q1 2025, and $42991.1 in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.69 Bn | 131.84 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.46 Bn | 78.47 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.62 Bn | 60.44 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.37 Bn | 53.24 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.73 Bn | 28.43 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.27 Bn | 9.87 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.58 Bn | 26.42 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.23 Bn | 26.40 Bn | - | 1.76 Bn |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 15,175.20 |
| Jan 31, 2025 | 24,061.11 |
| Jan 31, 2024 | 42,991.13 |
| Jan 31, 2023 | 56,128.01 |
| Oct 31, 2022 | 206,732.28 |
| Jul 31, 2022 | 187,707.49 |
| Apr 30, 2022 | 272,851.31 |
| Jan 31, 2022 | 903,006.42 |
| Oct 31, 2021 | 2.39 Mn |
| Jul 31, 2021 | 4.60 Mn |
| Apr 30, 2021 | 1.11 Mn |
| Jan 31, 2021 | 1.03 Mn |
| Oct 31, 2020 | 880,055.04 |
| Jul 31, 2020 | 1.48 Mn |
| Apr 30, 2020 | 1.49 Mn |
| Jan 31, 2020 | 2.65 Mn |
| Oct 31, 2019 | 5.74 Mn |
| Jul 31, 2019 | 6.89 Mn |
| Apr 30, 2019 | 145,643.21 |
| Jan 31, 2019 | 163,359.31 |